CLINICAL_TRIALS
trial_result
· 2016-07-21
Clinical Trial Update: Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Summary
Phase 2 study of CEP-701 (lestaurtinib) in patients with acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED